Utilizing the right tools for cell line development is essential for creating consistent and high-quality biotherapeutics. One of these key tools is the gene insertion technology used, either random or transposon-based integration. But which should you be using for your biotherapeutic workflow and is it worth switching from your current technology?
To help answer this question we’ve created an infographic that demonstrates the 3 pillars of productivity that will have you making the positive switch from random to transposon-based integration.
The CHOSOURCE Platform is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.
Gene insertion technologies for cell line development